NZNew Zealand's High Court has ruled that recent regulations restricting the prescription of puberty blockers for gender-diverse youth were unlawful. In 2025, the government introduced rules prohibiting new prescriptions of puberty blockers for children and adolescents with gender dysphoria or gender incongruence, citing concerns over potential harm. However, the court found that the government failed to properly consult with affected individuals, including gender-diverse youth, and that the restrictions unlawfully discriminated against this group, violating the Bill of Rights. The court emphasized that while some restrictions might be justified, a complete ban on new prescriptions was considered disproportionate. The ruling invalidated the regulations, allowing continued use of puberty blockers for existing patients and those with non-gender-related health conditions.
Bias read (Center): The article presents the court's ruling and includes perspectives from both PATHA and Family First NZ, providing balanced views on the issue. It does not exhibit clear bias toward either side but rather reports the legal outcome and reactions from different groups involved.
Why factuality (87): The article provides detailed information about the timeline of events including the 2025 government proposal, the 2024 public consultation, the majority opposition to restrictions, the minister's recommendation, and the subsequent judicial review by PATHA. It accurately describes the court's findin
Why objectivity (93): The article presents the facts in a neutral manner, avoiding overtly biased language. It reports the court's reasoning without taking sides, though it does imply the court's decision aligns with the views of gender-diverse individuals through its phrasing.
